Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial

The Lancet Oncology 2026

View at publisher
Authors: P. Nilsson, Adalsteinn Gunnlaugsson, L. Beckman, Anders Widmark, Per Fransson, Morten Hoyer, Magnus Lagerlund, Jon Kindblom, Bengt Johansson, Kirsten Björnlinger, Claes Ginman, Martha Olsson
+7 more Måns Agrup, Elisabeth Kjellén, Björn Zackrisson, Björn Tavelin, Lars G. Franzén, Harald Anderson, Camilla Thellenberg Karlsson
DOI: 10.1016/s1470-2045(25)00656-4
Cited by: 13
References: 25

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Advanced Radiotherapy Techniques

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
3
Pages
293–301
Publication date
5 February 2026
Language
EN